The FDA approved mitomycin gel (Jelmyto), the first therapy to treat low-grade upper tract urothelial cancer.
AstraZeneca announced it will be conducting a global clinical trial, CALAVI, to examine the impact of adding acalabrutinib to best supportive care for patients who are severely ill with the COVID-19 infection.
The registry, titled the ASCO Survey on COVID-19 in Oncology Registry, will collect both baseline and follow-up data throughout the COVID-19 pandemic and into 2021.
The practicing radiation oncologist highlighted the importance of being there for patients with cancer during the COVID-19 pandemic in an interview with CancerNetwork®.
ASCO released new recommendations regarding the allocation of resources for oncologists and institutions to consider during the COVID-19.
Researchers examined the pathology of early-phase COVID-19 pneumonia in two older patients who were admitted to the hospital for adenocarcinoma procedures, but did not exhibit COVID-19 symptoms at the time of these procedures.
The FDA granted priority review to the new drug application for sodium thiosulfate for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to <18 years of age with localized, non-metastatic, solid tumors.
A number of different healthcare organizations released specific guidelines for patients and healthcare professionals on how to best handle cancer care while dealing with the international COVID-19 pandemic.
Karyopharm Therapeutics announced plans to commence a global randomized clinical trial for low dose oral selinexor in hospitalized patients with severe COVID-19.
A recent study examined the literature surrounding the efficacy of radiotherapy as it pertains to each gender, showing that women are more likely to be cured of their cancer with radiotherapy treatment than men.